PANCREATIC DUCTAL CARCINOMA
Clinical trials for PANCREATIC DUCTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill JAB-3312 tested in patients with advanced cancers
Disease control CompletedThis early-stage trial tested an oral drug called JAB-3312 in 40 adults with advanced solid tumors (like lung, colon, or breast cancer) that had stopped responding to standard treatments. The main goals were to find a safe dose and check for side effects. Researchers also looked …
Matched conditions: PANCREATIC DUCTAL CARCINOMA
Phase: PHASE1 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-stage study tested a new drug combination (vobramitamab duocarmazine plus lorigerlimab) in 31 people with advanced solid tumors like prostate, melanoma, and pancreatic cancer. The main goal was to check safety and find the right dose. Participants received the drugs ev…
Matched conditions: PANCREATIC DUCTAL CARCINOMA
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC